DESCRIPTION

SUDOSCAN is a new method for sudomotor function assessment. It measures sweat composition to detect deviations in the ionic balance of sweat.

SUDOSCAN is used by medical practitioners to analyze sweat gland dysfunction associated with small nerve fiber neuropathy, not necessarily detectable in physiological conditions. It is non-invasive, painless, and takes only 2 minutes.
Quantitative results are expressed as Electrochemical Sweat Conductance (ESC, in microsiemens, µS) for the hands and feet. A relative risk score demonstrating the severity of dysautonomia is derived from ESC values and demographic data.

SUDOSCAN produces detailed reports and quantitative data, which further enhance the medical professional’s ability to pinpoint the etiology of disease resulting from disturbances in the Autonomic Nervous System (ANS). Keep in mind that about 33% of small fiber neuropathies remain idiopathic despite appropriate diagnostic evaluation.

Early detection of Small Fiber Neuropathy allows for continual management of a progressive disease. Routine quantifiable assessment necessitates an individualized patient-centric approach to the underlying causes of neuropathy.

SUDOSCAN has been tested for small fiber nerve neuropathies in several diseases and compared to guidelines reference tests:

• Diabetes

• Parkinson

• Chemotherapy induced polyneuropathy

• Familial amyloid polyneuropathy

• Fabry disease

Diabetes complications

Cardiovascular Autonomic Neuropathy (CAN) is clinically the most critical form of diabetic autonomic neuropathy. It is caused by a loss of autonomous cardiac innervation and results in diminished Heart Rate Variability (HRV) and vascular dynamics. Detecting CAN early can help prevent sudden cardiac death and myocardial infarction. HRV has proven to be a predictor for all-cause mortality but is time consuming and requires specific diagnostic equipment.

SUDOSCAN is an innovative device to detect and follow-up cardiac autonomic neuropathy.